Pixee Medical's Knee+ NexSight Revolutionizes Knee Surgeries with FDA-Approved Augmented Reality Precision
April 22, 2025
Pixee Medical has received FDA 510(k) clearance for its innovative product, Knee+ NexSight, which is an augmented reality solution designed specifically for total knee arthroplasty in U.S. ambulatory surgery centers.
The technology enables surgeons to position knee implants with high accuracy tailored to each patient's specifications, eliminating the need for expensive preoperative imaging.
Built on insights from orthopedic surgeons, Knee+ NexSight has successfully performed over 10,000 procedures globally, demonstrating its effectiveness in enhancing surgical efficiency.
Pixee Medical specializes in augmented reality solutions for orthopedic surgery, with its technologies already positively impacting practices in over 20 countries.
An optional connectivity module enhances workflow integration by allowing secure data exchange with third-party web solutions, preparing surgical teams for future technological advancements.
Additionally, Knee+ NexSight is designed to minimize environmental impact by reducing physical disposables, making it a sustainable option for surgical environments.
The first product from Pixee Medical has already demonstrated significant global success, showcasing the potential of augmented reality in improving the precision and efficiency of orthopedic surgeries.
Overall, Knee+ NexSight represents a cost-effective solution that meets the evolving demands of the orthopedic surgical landscape.
Its full compatibility with existing implant systems and integration into standard surgical procedures facilitates an easy learning curve for users.
Knee+ NexSight offers robotic-like precision in a user-friendly format, allowing surgeons to make accurate intraoperative decisions without the complexities or costs associated with traditional robotic systems.
This solution is particularly timely as it addresses the needs of the rapidly growing U.S. ambulatory surgical center market, projected to exceed $75 billion by 2030.
Knee+ NexSight is compatible with all major total knee implants and is designed to fit various surgical settings, from outpatient centers to hospitals.
Summary based on 2 sources